Plunkett Research Online: AxoGen Inc

AXOGEN INC (AXGN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AxoGen, Inc. is a regenerative medicine company focused on the development and commercialization of technologies for peripheral nerve reconstruction and regeneration. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body and their damage can result in the loss.....



AxoGen Inc
Ticker: AXGN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 888 296-4361
Fax: 386-462-6801
Address: 13631 Progress Boulevard
Suite 400
Alachua, FL 32615 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Electromedical and Electrotherapeutic Apparatus Manufacturing
ContactsDescription
Karen ZaderejCEO/Director/President/Chairman of the Board
Peter MarianiCFO/Chief Accounting Officer
See More
AxoGen, Inc. is a regenerative medicine company focused on the development and commercialization of technologies for peripheral nerve reconstruction and regeneration. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body and their damage can result in the loss.....See More See More

Auditor: Lurie LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: